GOLIATH VS. EVERYBODY
‘Big business versus everybody else’: small cannabis businesses struggle
The US cannabis industry could be emerging as a David-versus-Goliath kind of landscape, reports MJBizDaily, pointing to a number of recent cases that illustrate why.
A few examples:
- Michigan’s tense disagreement between the large company-backed Cannabis Manufacturer’s Association and smaller companies, which has resulted in brand boycotts
- MSO efforts in Arizona to take over social equity licenses and in Illinois to block canopy increases for craft cultivators
- Industry-led efforts to stamp out home growing in New York
“I think it kind of is ‘big business’ versus everybody else,” said Detroit attorney and industry veteran Matt Abel.
Enjoy Cannabis Daily each morning at 7 a.m.
How the cannabis industry is supporting Ukraine
The cannabis industry is stepping up to support Ukrainian refugees and those left behind as Russia continues its violent attack on the country, reports High Times.
- San Francisco’s MediThrive is raising money for the Sunflower of Peace non-profit
- Detroit’s Luxury Loud is hosting a “pot and pierogies” fundraiser for UNICEF
- PR firm Mattio Communications is matching donations of up to $3,000 to the UN Refugee Agency, Kyiv Indepdendent, Voices of Children and more
For Misha Breyburg, the Ukrainian-Jewish CEO of San Francisco-based MediThrive, the issue hits close to home because he fled to the US as a child in the 70s. “I couldn’t live with myself if I didn’t do something.”
WHAT’S UP DOC?
Health Canada comes down on medical cannabis
Both home-growing applicants and medical doctors are facing scrutiny from Health Canada over access to medical cannabis.
On Twitter, cannabis advocate Janeen Davis posted a letter received by an applicant to grow medical cannabis from Health Canada demanding additional information about the daily amount they’re authorized to use daily.
And in Medicine Hat, Dr. Gaylord Wardell was found guilty of professional misconduct by the College of Physicians and Surgeons of Alberta for issues pertaining to medical cannabis, reports CTV. The decision concluded that he didn’t look for more conventional treatments before authorizing cannabis; didn’t follow up with patients every three months and didn’t look at contraindications with other prescriptions before authorizing cannabis.
Love Hemp’s battle with shareholders
A major shareholder of UK CBD company Love Hemp is demanding the chairman step down, salaries of the board be reduced by 75% and that the company engages in a review of its spending, reports BusinessCann.
Pershing Nominees Limited owns 79,505,999 shares—more than 5% of the total paid-up capital and 9.6% of the total issued share capital—of the company. Love Hemp stock has dropped by 30%
The resolutions will be voted on by shareholders on April 1.